Justin Bowers
Stock Analyst at Deutsche Bank
(2.61)
# 2,146
Out of 4,735 analysts
49
Total ratings
41.94%
Success rate
6.18%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $413.81 | -21.46% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $205.69 | +28.83% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $18.70 | +22.99% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.30 | +30.04% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $92.18 | +9.57% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $347.52 | -3.31% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $16.16 | +54.70% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $167.92 | -7.69% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $573.06 | +6.45% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $78.75 | +4.13% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $21.77 | +14.84% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $5.23 | +225.05% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $205.07 | +46.29% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $244.11 | +12.65% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $344.69 | -27.47% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $169.81 | +70.78% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $19.33 | +137.97% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $413.81
Upside: -21.46%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $205.69
Upside: +28.83%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $18.70
Upside: +22.99%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.30
Upside: +30.04%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $92.18
Upside: +9.57%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $347.52
Upside: -3.31%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $16.16
Upside: +54.70%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $167.92
Upside: -7.69%
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $573.06
Upside: +6.45%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $78.75
Upside: +4.13%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $21.77
Upside: +14.84%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $5.23
Upside: +225.05%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $205.07
Upside: +46.29%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $244.11
Upside: +12.65%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $344.69
Upside: -27.47%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $169.81
Upside: +70.78%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $19.33
Upside: +137.97%